Monsanto, EPA colluded to kill cancer findings
Some 17 cancer experts from 11 countries reviewed the evidence and already unanimously came to this conclusion in 2015 about the blockbuster weedkiller. The International Agency for Research on Cancer (IARC) had called for the review.
Monsanto has touted the approval of the chemical by the Environmental Protection Agency (EPA), but newly unsealed court documents released this week, show a startling effort on the part of both Monsanto and the EPA to work in concert to discredit independent cancer research conducted by the World Health Organisation’s International Agency the IARC.
Excerpts from the document show how the EPA effectively declared Roundup safe for use without conducting tests on the actual formulation, but instead relying on industry research on just one of the product’s active ingredients.
“EPA’s minimal standards do not require human health data submissions related to the formulated product – here, Roundup. Instead, EPA regulations require only studies and data that relate to the active ingredient, which in the case of Roundup is glyphosate. As a result, the body of scientific literature EPA has reviewed is not only primarily provided by the industry, but it also only considers one part of the chemical ingredients that make up Roundup.”
Glyphosate, the main ingredient in the Monsanto’s flagship product Roundup, the most widely applied pesticide worldwide.